Cargando…

Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†

OBJECTIVES: Atrial fibrillation (AF) reduces survival and quality of life (QoL). It can be treated at the time of major cardiac surgery using ablation procedures ranging from simple pulmonary vein isolation to a full maze procedure. The aim of this study is to evaluate the impact of adjunct AF surge...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashef, Samer A M, Fynn, Simon, Abu-Omar, Yasir, Spyt, Tomasz J, Mills, Christine, Everett, Colin C, Fox-Rushby, Julia, Singh, Jeshika, Dalrymple-Hay, Malcolm, Sudarshan, Catherine, Codispoti, Massimiliano, Braidley, Peter, Wells, Francis C, Sharples, Linda D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134441/
https://www.ncbi.nlm.nih.gov/pubmed/29672731
http://dx.doi.org/10.1093/ejcts/ezy165
_version_ 1783354659574906880
author Nashef, Samer A M
Fynn, Simon
Abu-Omar, Yasir
Spyt, Tomasz J
Mills, Christine
Everett, Colin C
Fox-Rushby, Julia
Singh, Jeshika
Dalrymple-Hay, Malcolm
Sudarshan, Catherine
Codispoti, Massimiliano
Braidley, Peter
Wells, Francis C
Sharples, Linda D
author_facet Nashef, Samer A M
Fynn, Simon
Abu-Omar, Yasir
Spyt, Tomasz J
Mills, Christine
Everett, Colin C
Fox-Rushby, Julia
Singh, Jeshika
Dalrymple-Hay, Malcolm
Sudarshan, Catherine
Codispoti, Massimiliano
Braidley, Peter
Wells, Francis C
Sharples, Linda D
author_sort Nashef, Samer A M
collection PubMed
description OBJECTIVES: Atrial fibrillation (AF) reduces survival and quality of life (QoL). It can be treated at the time of major cardiac surgery using ablation procedures ranging from simple pulmonary vein isolation to a full maze procedure. The aim of this study is to evaluate the impact of adjunct AF surgery as currently performed on sinus rhythm (SR) restoration, survival, QoL and cost-effectiveness. METHODS: In a multicentre, Phase III, pragmatic, double-blinded, parallel-armed randomized controlled trial, 352 cardiac surgery patients with >3 months of documented AF were randomized to surgery with or without adjunct maze or similar AF ablation between 2009 and 2014. Primary outcomes were SR restoration at 1 year and quality-adjusted life years at 2 years. Secondary outcomes included SR at 2 years, overall and stroke-free survival, medication, QoL, cost-effectiveness and safety. RESULTS: More ablation patients were in SR at 1 year [odds ratio (OR) 2.06, 95% confidence interval (CI) 1.20–3.54; P = 0.009]. At 2 years, the OR increased to 3.24 (95% CI 1.76–5.96). Quality-adjusted life years were similar at 2 years (ablation − control −0.025, P = 0.6319). Significantly fewer ablation patients were anticoagulated from 6 months postoperatively. Stroke rates were 5.7% (ablation) and 9.1% (control) (P = 0.3083). There was no significant difference in stroke-free survival [hazard ratio (HR) = 0.99, 95% CI 0.64–1.53; P = 0.949] nor in serious adverse events, operative or overall survival, cardioversion, pacemaker implantation, New York Heart Association, EQ-5D-3L and SF-36. The mean additional ablation cost per patient was £3533 (95% CI £1321–£5746). Cost-effectiveness was not demonstrated at 2 years. CONCLUSIONS: Adjunct AF surgery is safe and increases SR restoration and costs but not survival or QoL up to 2 years. A continued follow-up will provide information on these outcomes in the longer term. STUDY REGISTRATION: ISRCTN82731440 (project number 07/01/34).
format Online
Article
Text
id pubmed-6134441
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-61344412018-09-14 Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation† Nashef, Samer A M Fynn, Simon Abu-Omar, Yasir Spyt, Tomasz J Mills, Christine Everett, Colin C Fox-Rushby, Julia Singh, Jeshika Dalrymple-Hay, Malcolm Sudarshan, Catherine Codispoti, Massimiliano Braidley, Peter Wells, Francis C Sharples, Linda D Eur J Cardiothorac Surg General Adult Cardiac OBJECTIVES: Atrial fibrillation (AF) reduces survival and quality of life (QoL). It can be treated at the time of major cardiac surgery using ablation procedures ranging from simple pulmonary vein isolation to a full maze procedure. The aim of this study is to evaluate the impact of adjunct AF surgery as currently performed on sinus rhythm (SR) restoration, survival, QoL and cost-effectiveness. METHODS: In a multicentre, Phase III, pragmatic, double-blinded, parallel-armed randomized controlled trial, 352 cardiac surgery patients with >3 months of documented AF were randomized to surgery with or without adjunct maze or similar AF ablation between 2009 and 2014. Primary outcomes were SR restoration at 1 year and quality-adjusted life years at 2 years. Secondary outcomes included SR at 2 years, overall and stroke-free survival, medication, QoL, cost-effectiveness and safety. RESULTS: More ablation patients were in SR at 1 year [odds ratio (OR) 2.06, 95% confidence interval (CI) 1.20–3.54; P = 0.009]. At 2 years, the OR increased to 3.24 (95% CI 1.76–5.96). Quality-adjusted life years were similar at 2 years (ablation − control −0.025, P = 0.6319). Significantly fewer ablation patients were anticoagulated from 6 months postoperatively. Stroke rates were 5.7% (ablation) and 9.1% (control) (P = 0.3083). There was no significant difference in stroke-free survival [hazard ratio (HR) = 0.99, 95% CI 0.64–1.53; P = 0.949] nor in serious adverse events, operative or overall survival, cardioversion, pacemaker implantation, New York Heart Association, EQ-5D-3L and SF-36. The mean additional ablation cost per patient was £3533 (95% CI £1321–£5746). Cost-effectiveness was not demonstrated at 2 years. CONCLUSIONS: Adjunct AF surgery is safe and increases SR restoration and costs but not survival or QoL up to 2 years. A continued follow-up will provide information on these outcomes in the longer term. STUDY REGISTRATION: ISRCTN82731440 (project number 07/01/34). Oxford University Press 2018-10 2018-04-17 /pmc/articles/PMC6134441/ /pubmed/29672731 http://dx.doi.org/10.1093/ejcts/ezy165 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle General Adult Cardiac
Nashef, Samer A M
Fynn, Simon
Abu-Omar, Yasir
Spyt, Tomasz J
Mills, Christine
Everett, Colin C
Fox-Rushby, Julia
Singh, Jeshika
Dalrymple-Hay, Malcolm
Sudarshan, Catherine
Codispoti, Massimiliano
Braidley, Peter
Wells, Francis C
Sharples, Linda D
Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title_full Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title_fullStr Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title_full_unstemmed Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title_short Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
title_sort amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation†
topic General Adult Cardiac
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134441/
https://www.ncbi.nlm.nih.gov/pubmed/29672731
http://dx.doi.org/10.1093/ejcts/ezy165
work_keys_str_mv AT nashefsameram amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT fynnsimon amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT abuomaryasir amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT spyttomaszj amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT millschristine amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT everettcolinc amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT foxrushbyjulia amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT singhjeshika amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT dalrymplehaymalcolm amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT sudarshancatherine amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT codispotimassimiliano amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT braidleypeter amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT wellsfrancisc amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation
AT sharpleslindad amazearandomizedcontrolledtrialofadjunctsurgeryforatrialfibrillation